Crossmark

Fatty acid binding protein 7 may be a marker and therapeutic targets in clear cell renal cell carcinoma

Crossref DOI link: https://doi.org/10.1186/s12885-018-5060-8

Published Online: 2018-11-15

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Nagao, Kazuhiro

Shinohara, Nachi

Smit, Frank

de Weijert, Mirjam

Jannink, Sander

Owada, Yuji

Mulders, Peter

Oosterwijk, Egbert

Matsuyama, Hideyasu
License Information

Text and Data Mining valid from 2018-11-15
More Information

Article History

Received: 30 July 2017

Accepted: 7 November 2018

First Online: 15 November 2018

Ethics approval and consent to participate

: Written informed consent was obtained from all the participants and the analysis was ethically approved at our institution. The approval number from the ethics committee is CWOM9803–0060 in Radboud University Medical Center. The approval number from the ethics committee is H27–023-3 in Yamaguchi University Hospital.

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.